Glaxo's Avandia Prescriptions Drop After Heart Report (Update3) – Bloomberg


    Glaxo's Avandia Prescriptions Drop After Heart Report (Update3)
    Bloomberg - 1 hour ago
    June 6 (Bloomberg) — Doctors wrote 40 percent fewer new prescriptions for GlaxoSmithKline Plc's diabetes drug Avandia after a ( Prescriptions ) and a May 21 report that linked it
    Risks of Glaxo diabetes drug still unclear: FDA Washington Post
    ei=fDxnRrfRCpXC0gHZ86jsDQ”>Glaxo's Avandia Prescriptions Fall After Study, Goldman Says Bloomberg
    Avandia prescriptions fall after safety questioned Reuters
    all 649 news articles

Comments are closed.